Summer Research
Contact
1020 Locust Street
Room 368
Philadelphia, PA 19107
Highlighted Publications
Steplewski, A., Fertala, J., Arita, M., Romero, F., Summer, R., Fertala, R. Target-Specific Delivery of an Antibody That Blocks the Formation of Fibrotic Deposits in Keloid and Lung Fibrosis Models, Monoclon Antib Immunodiagn Immunother. [201728972447]
This study demonstrates our ability to deliver a novel antifibrotic antibody to the lung and provides preliminary evidence that this biologic may be effective in the treatment of pulmonary fibrosis.
Freddy Romero, Xu Hong, Dilip Shah, Caleb B. Kallen, Ivan Rosas, Zhi Guo, DeLeila Schriner, Julie Barta, Hoora Shaghaghi, Jan B. Hoek, Clementina Mesaros, Augustine M. Choi, Nathaniel W. Snyder, and Ross Summer, Lipid synthesis is required to resolve ER stress and limit fibrotic responses in the lung Am J Respir Cell Mol Biol. 2018.
This study provides a unifying mechanism linking ER stress to the development of pulmonary fibrosis. We show that metabolic dysfunction, namely the impairment of lipid synthesis, reduces the capacity of alveolar epithelial cells to resolve ER stress, leading to sustained cellular dysfunction and induction of fibrotic responses. We also provide evidence that pharmacological or dietary approaches to increasing lung lipids could be effective in treating pulmonary fibrosis.
Romero F, Shah D, Duong M, Penn RB, Fessler MB, Madenspacher J, Stafstrom W, Kavuru M, Lu B, Kallen CB, Walsh K, Summer R. A Pneumocyte-macrophage Paracrine Lipid Axis Drives the Lung Toward Fibrosis. Am J Respir Cell Mol Biol. 2014 Nov 19. E-pub ahead of print [PMID:25409201].
This study is the first to suggest that macrophage foam cells play a causal role in the development of pulmonary fibrosis and that strategies aimed at blocking their formation might be effective in limiting the onset and progression of disease.
Publications
- Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
- Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
- Letter to the editor in response to article "Use of statins in patients with established idiopathic inflammatory myopathies"
- Combination Treatment of Biochanin A and Atorvastatin Alters Mitochondrial Bioenergetics, Modulating Cell Metabolism and Inducing Cell Cycle Arrest in Pancreatic Cancer Cells
- Pressed for understanding: Interstitial lung disease in dry-cleaning workers
- Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013–2023)
- Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis
- Reclaiming the Balance: Blocking Glutamine Uptake to Restrain Pulmonary Fibrosis
- Changes in nascent chromatin structure regulate activation of the pro-fibrotic transcriptome and myofibroblast emergence in organ fibrosis
- Moving senolytics closer to the clinic in IPF
- Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome
- 68-year old man with progressive weakness and ventilator dependent respiratory failure: a case report of sporadic late onset nemaline myopathy
- Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study
- The profibrotic and senescence phenotype of old lung fibroblasts is reversed or ameliorated by genetic and pharmacological manipulation of Slc7a11 expression
- Hermansky-Pudlak syndrome-2 alters mitochondrial homeostasis in the alveolar epithelium of the lung
- Glutamine restores mitochondrial respiration in bleomycin-injured epithelial cells